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ABSTRACT  Bovine retina  and  hypothalamus  contain  anionic endothelial  cell  mitogens that display 
unusual affinities  for the negatively charged glycosaminoglycan  heparin. Both growth factor activities 
are acidic polypeptides (pl's  of 5.0) as determined  by isoelectric  focusing and  DEAE-affinity chro- 
matography.  In spite of their anionic nature, the factors bound to heparin-Sepharose columns with 
high affinity and could be eluted only at high salt concentrations  (0.9-1.1  M  NaCI). The affinity of 
the  retina-derived  growth  factor  (RDGF) for  heparin  permitted  a  15,000-fold  purification  of the 
mitogen in two steps: heparin-affinity chromatography and size exclusion  high-performance  liquid 
chromatography.  RDGF and the anionic hypothalamus-derived  factor (aHDGF) exhibit three major 
biochemical  similarities including isoelectric  point, (pl's of 5.0), heparin affinity (elution at 0.9-1.1  M 
NaCI) and molecular weight (18,000). Additionally, the two factors display similar biological activities, 
stimulating  the proliferation of capillary and human umbilical  vein endothelial and 3T3 cells but not 
vascular smooth  muscle cells. We suggest that RDGF and aHDGF are related if not identical  growth 
factor molecules. 
In a normal, adult tissue the endothelium exhibits a very low 
rate of turnover. The mitotic indices of the capillary endothe- 
lium have been documented to be 0.14% in the myocardium 
and as low as 0.01% in the retina (7). Yet, there are a number 
of conditions, both normal and pathological, in which endo- 
thelial cell  proliferation increases.  Inflammation,  psoriasis, 
tumor growth, formation of the corpus luteum, and diabetic 
retinopathy all involve dramatic levels of new blood vessel 
growth. It is not clear in any of these cases what causes the 
stable growth controls that the endothelium appear to possess 
to go awry. Because proliferation is central to the formation 
of new blood vessels, factors that influence endothelial cell 
(EC) ~ proliferation may be involved. 
EC mitogens have been identified in a wide variety of cells 
and tissues, including cartilage (17), tumors (21), platelets (4), 
brain (12,  15,  23), hypothalamus (18), and pituitary (9,  11). 
The relationship of these EC mitogens to one another (if any) 
is unclear. We (5,  10) and others (1) have previously demon- 
strated that extracts of bovine retina also contains a  petent 
EC growth factor, retina-derived growth factor (RDGF). The 
recent finding by our group that an EC growth facto~ from 
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chondrosarcoma  exhibits  a  strong  affinity  for  an  anionic 
glycosaminoglycan heparin (21) prompted us to examine the 
binding of RDGF  to  immobilized heparin.  We  have  now 
found that RDGF, which we know to be anionic, also displays 
a strong affinity for heparin. We used this unexpected affinity 
for heparin  to  facilitate the  isolation of this growth  factor 
from retina. We also investigated the nature of another EC 
mitogen  that  has  been  described to  exist in  hypothalamus 
(19).  Here  we  show  that  this  mitogen  shares  a  number  of 
biochemical  characteristics  and  biological  functions  with 
RDGF and appears to be similar if  not identical to the RDGF. 
MATERIALS AND  METHODS 
Cell Culture and Proliferation  Assays:  Capillary  endothelial  ce~. 
Bovine capillary EC from adrenal cortex were generously  given to us by Dr. J. 
Folkman (The Children's Hospital, Boston, MA) and cultured as previously 
described  (8). The growth factor  activity  of  column fractions  obtained  through- 
out purification and characterization  was assessed  as  follows.  Capillary EC 
(passages 3-10) were plated at 10,000 per well in 2.1 cra  2 multiwell  dishes 
(Nunc, Vanguard International,  N  J) in Dulbecco's  modified  Eagle's  medium 
with 10%  calf serum. The cells were allowed to attach and recover from 
trypsinization  overnight.  The unattached  cells  and medium were  aspirated  and 
0.5 ml of fresh medium was added together with the fraction to be tested in 
volumes up to 50 ~l. 2 d later the cells  were removed  by trypsinization  and cell 
number determined  with a Coulter  Counter (Coulter  Electronics,  Inc., Hialeah, 
FL). 
BALB/c 37"3 Cells:  Growth  factor activity in column fractions was 
also monitored by measuring the stimulation of [methyl-3H]thymidine  incor- 
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synthesis in quiescent monolayers of 3T3 cells, and procedures for maintaining 
the 3T3 cell cultures have been previously described (16). A unit of 3T3 cell 
stimulatory activity was defined as the amount of growth factor required to 
yield half-maximal [3H]thymidine incorporation by the 3T3 cells. 
Preparation of Retinal Extract:  Retinas which were dissected from 
bovine eyes were incubated  in Hank's balanced salt solution (one retina per 
milliliter) for 3 h at room temperature as previously described (10). The retinas 
were removed by centrifugation and the extract was subjected to the following 
separation techniques. 
Hypothalamus-derived Growth Factor:  A crude salt (0.15 M 
NaCI) extract  of bovine  hypothaiami  (Endothelial Mitogen) was purchased 
from Biomedical Technologies Inc., Cambridge, MA. The anionic hypothala- 
mus-derived  growth  factor  (aHDGF)  used  in this study  was  obtained  by 
fractionation of the crude hypothalamic extract by IEF as described below. 
Isoelectric Focusing:  Isoelectric focusing (IEF) was conducted  for 
both analytical and preparative purposes using an LKB 8100 vertical electro- 
focusing column. Ampholytes (LKB Instruments, Bromma, Sweden) from pH 
3.5 to 10 were distributed on a linear sucrose density gradient (5-50% wt/vol). 
The crude retinal extract which had been dialyzed extensively against water 
was introduced at the time of gradient formation. Samples were focused at a 
constant voltage of 820 V for 24 h at 4"C. 55 2-ml fractions were then collected 
and their pHs were determined. The fractions were pooled in groups of three, 
dialyzed first against 1.0 M NaC1 to facilitate the removal of the ampholytes, 
then exhaustively dialyzed against deionized, distilled water. Dialysis tubing 
with a molecular weight cut-off of 3,500 (Spectrum Medical Industries, CA) 
was used in all dialysis steps. The samples were then lyophilized and tested for 
their ability to stimulate capillary EC proliferation and 3T3 cell DNA synthesis. 
Heparin-Sepharose Affinity Chromatography:  Heparin-Seph- 
arose affinity chromatography  was conducted  using a 7 x  1 cm column  of 
heparin-Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated 
in 0.1 M NaCI, 0.01 M Tris-HCl, pH 7.4, at 4"C. The active fractions obtained 
from IEF of RDGF and aHDGF were dialyzed against the column equilibration 
buffer and applied to separate columns of heparin-Selaharose.  After rinsing with 
equilibration buffer the growth factors were eluted with a gradient of 0.1 to 3.0 
M NaCI in 0.01 M Tris-HC1 at 40 ml/h. The fractions were then dialyzed as 
after the IEF column. 
Size Exclusion Chromatography:  Both the crude retinal extract 
and the peak of growth factor activity obtained from heparin-Sepharose chro- 
matography were fractionated on a TSK 2000 size exclusion column (Varian, 
8ram I.D. x  50 cm), which was equilibrated with 0.6 M NaCI, 0.02 M Tris- 
HC1, pH 7.0, using a Beckman model 334 HPLC system (Beckman Instru- 
ments, Palo Alto, CA). HPLC was conducted at room temperature  at a flow 
rate of 0.5 ml/min. Fractions (0.8 ml) were collected, dialyzed as above, and 
tested for their ability to stimulate  proliferation  of capillary EC and DNA 
synthesis by 3T3  cells. Blue dextran  (2  x  10~), serum  albumin (68,000), 
ovalbumin (43,000), a-chymotrypsinogen (25,700), and lysozyme  (14,300) were 
used to calibrate the column. 
RESULTS 
Characterization  of RDGF 
We had reported previously that bovine retina can release 
under the extraction procedures described here a  polypeptide 
factor that is mitogenic for  fetal aortic  and capillary EC  as 
well  as  BALB/c  3T3  cells  (5,  10).  Analysis  of this  retinal 
extract by IEF revealed a  single peak of growth factor activity 
that  focused  with  a  pI  of  5.6  _+  0.3  and  stimulated  the 
proliferation of capillary EC as well as DNA synthesis by 3T3 
cells (Fig.  1). 
The growth factor activity obtained from IEF shown in Fig. 
1  was  applied  to  a  column  of heparin-Sepharose  (Fig.  2). 
Whereas >90% of the applied protein eluted from the column 
in the void volume (protein profile not shown), most of the 
remaining  protein  was  eluted  from  the  heparin-Sepharose 
before 0.5 M  NaC1. Less than 8% of the growth factor activity 
was  associated  with  the  void  volume.  The  majority  of the 
growth  factor activity eluted  from  the column  between  0.9 
and  1.1  M  NaCI as a  single peak of activity that stimulated 
both the capillary endothelial and the 3T3 cells. Similar results 
were obtained when the crude extract was applied directly to 
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FIGURE 1  IEF profile of RDGF. Crude retinal extract (30 ml,  180 
mg  protein) was  analyzed by  IEF  on  a  vertical electrofocusing 
column  using ampholytes of  pH  3.5-10  distributed on  a  linear 
sucrose density gradient.  55 2-ml fractions were collected and the 
pH (A) determined. The fractions were pooled in groups of three, 
dialyzed first  against 1.0 M  NaCI to facilitate the removal of the 
ampholytes and then against deionized, distilled water.  The frac- 
tions were then lyophilized, dissolved in phosphate-buffered saline 
and tested for their growth factor activity.  A representative column 
is shown in this figure.  EC number (O) is the average of triplicate 
wells:  3T3 cells [3H]thymidine incorporation (Q) is the average of 
two wells. 
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FIGURE 2  Heparin-Sepharose chromatography of RDGF obtained 
from  IEF. The peak of growth factor activity obtained from  IEF 
(fractions  12-22; Fig. 1) was dialyzed against 0.1  M  NaCl, 0.01 M 
Tris-HCI, pH 7.4, and applied to a column of heparin-Sepharose (1 
x  7 cm) equilibrated in the same buffer.  After a 30-ml rinse with 
the equilibration buffer the protein was eluted at 40 ml/h with a 
gradient of 0.1-3.0 M  NaCl (200 ml). The fractions were dialyzed 
against deionized, distilled water and tested for their growth factor 
activity. A representative column profile is shown in this figure. EC 
number (O) is the average of triplicate wells; 3T3 cell [3H]thymidine 
incorporation (Q) is the average of two wells. 
the immobilized heparin (data not shown). Application of the 
RDGF,  partially  purified by  heparin-Sepharose  chromatog- 
raphy, to an HPLC TSK 2000 size exclusion column yielded 
the profile shown in Fig. 3. One peak of growth factor activity 
was  obtained  and  was  eluted  with  a  molecular  weight  of 
~  18,000. 
The combination of heparin-affinity chromatography with 
either IEF or size exclusion chromatography resulted in the 
isolation of a  highly purified growth factor activity. Table I 
illustrates the results of analysis of RDGF  by heparin-Sepha- 
rose  and  size  exclusion.  This  scheme  increased  the  specific 
activity of the growth factor 15,000-fold from  133 U/mg to 2 X  106 U/mg. At this level of purity, RDGF stimulated EC 
proliferation at concentrations of 1-I0 ng/ml.  SDS PAGE 
analysis  with  silver  stain  visualization  was  performed  on 
RDGF purified by heparin-Sepharose and  TSK 2000  size 
exclusion  chromatography. About  10  bands  were  evident, 
including a predominant band that migrated with a molecular 
weight of 17,800. This band is a likely candidate for RDGF 
based on the elution of growth factor activity from an HPLC 
TSK 2000 size exclusion column. 
Comparison of RDGF and aHDGF 
The EC growth factor from hypothalamus has  been  re- 
ported to have an isoelectric point of approximately 5.0 (19). 
We have confirmed this finding by IEF (data not shown). 
Separation of both RDGF and aHDGF by IEF both gave a 
single  peak of growth factor activity with a  pI of 5.0.  The 
peaks  of these  activities obtained  by IEF were applied  to 
separate  columns  of heparin-Sepharose.  Fig.  4  shows  that 
both RDGF and the aHDGF activity bound to heparin and 
eluted at  the  same  NaC1 concentration (0.9-1.1  M).  Both 
growth factors stimulated DNA synthesis by 3T3 cells (Fig. 4, 
top) as well as the proliferation of capillary endothelium (Fig. 
4, bottom). When RDGF and the aHDGF prepared by hep- 
arin-Sepharose chromatography were analyzed by size exclu- 
sion chromatography, the growth factor activities eluted in 
exactly the same fractions; this result indicates that they are 
of similar molecular size, approximately 18,000 (Fig. 5). 
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FIGURE 3  Size exclusion chromatography of RDGF obtained from 
heparin-Sepharose.  The peak of growth  factor activity that  was 
eluted from heparin-Sepharose  between 0.9 and 1.1 M  NaCI was 
dialyzed against deionized, distilled water, lyophilized, and resus- 
pended in  100 ~l of 0.6 M  NaCI, 0.02  M  Tris-HCI,  pH  7.0. The 
growth factor was then fractionated on a TSK 2000 size exclusion 
column equilibrated in the same buffer at room temperature with 
a flow rate of 0.5 ml/min. Fractions (0.8 ml) were collected, dialyzed 
against  deionized, distilled  water,  and  tested  for  growth  factor 
activity.  A representative column profile is shown in this figure. EC 
number (O) is the average of triplicate wells; 3T3 cell [3H]thymidine 
incorporation (0) is the average of two wells. The elution positions 
of molecular weight standards are indicated. 
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FIGURE 4  Comparison  of  RDGF and  aHDGF by  heparin-sepharose 
affinity  chromatography. RDGF (30 ml)  and aHDGF (16 ml)  activity 
that focused at pH 5.0 were dialyzed against 0.1 M  NaCI, 0.01 M 
Tris-HCI,  pH 7.4, and applied to separate heparin-Sepharose col- 
umns (1 x  7 cm). After rinsing (50 ml for RDGF, 40 ml for aHDGF) 
with equilibration buffer, a gradient of 0.1 to 3.0 M  NaCI (200 ml 
for RDGF, 320 ml for aHDGF)  was applied and the protein was 
eluted from the column at 40 ml/h. The fractions  were dialyzed 
against deionized, distilled water, lyophilized,  and tested for growth 
factor activity.  Representative  column profiles are shown  in  this 
figure. The top panel compares RDGF (O) and aHDGF (O) stimula- 
tion of [3H]thymidine incorporation by 3T3 cells; thymidine incor- 
poration is the average of duplicate wells. The bottom panel com- 
pares RDGF (O) and aHDGF (@) stimulation of EC proliferation; cell 
number is the average of triplicate wells. 
DISCUSSION 
We have previously demonstrated that an EC mitogen could 
be extracted from the retina by incubation in a balanced salt 
solution (10). Subsequent studies demonstrated that the activ- 
ity was  protease-sensitive and bound to DEAE cellulose (5) 
but not to CM cellulose (D'Amore, P. A., unpublished results). 
Together, these results indicate that the active molecule is an 
anionic polypeptide. Earlier estimates  of molecular weight 
based on behavior during dialysis and ultrafiltration studies 
TABLE I 
Purification of RDGF 
Protein*  Activity  Specific activity  Recovery  X-fold purification 
mg  U  t  U/mg  % 
Crude extract (10 ml)  60  8,000  133  100  1 
Heparin-Sepharose  0.009  4,400  490,000  55  3,600 
HPLC TSK 2000  0.0009  1,800  2 x  106  27.5  15,000 
* Protein  concentration  of the crude extract  and the heparin-Sepharose-purified  activity  was determined  by Lowry.  Comparative  density  on silver  stained  SDS 
polyacrylamide  gels  was used for protein determination  of the HPLC  TSK-purified  material. 
t A unit is defined as the amount  of growth factor required  to give half-maximal  [3H]thymidine  incorporation  by 3T3 cells. 
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FIGURE  5  Comparison of RDGF and aHDGF by HPLC size exclu- 
sion  chromatography.  The  peaks  of  RDGF  and  aHDGF  activity 
which were eluted from heparin-Sepharose by 0.9-1.1 M  NaCI (Fig. 
4) were dialyzed against deionized, distilled water, lyophilized, and 
then resuspended each in 100 t~l of 0.6 M  NaCI, 0.02 M  Tris-HCI, 
pH  7.0. The growth factors activities were then fractionated on a 
TSK  2000  size  exclusion  column  (Varian,  8  mm  I.D.  x  50  cm) 
equilibrated in the same buffer at room temperature with a flow 
rate of 0.5  ml/min.  Fractions (0.8 ml) were collected, dialyzed as 
above, and tested for their growth factor activity.  Representative 
column profiles are shown in this figure. The top panel illustrates 
the effect of  RDGF  on  capillary endothelial cell  proliferation (O) 
and [3H]thymidine incorporation by 3T3 cells (0). The bottom panel 
is a parallel experiment conducted with aHDGF.  EC number is an 
average of triplicate wells; 3T3 cell [3H]thymidine incorporation is 
the average of two wells. The elution positions of the  molecular 
weight standards are indicated. 
indicated a molecular weight of >50,000. Whether this larger 
molecular weight form is due to nonspecific associations or 
the existence of a specific carrier molecule is unknown. How- 
ever, the tendency of the activity to aggregate  made column 
chromatography in low salt buffers difficult. Only in presence 
of high concentrations of chaotropic agents such as guanidine 
was significant resolution of the activity accomplished. With 
HPLC size exclusion chromatography in 6 M guanidine, the 
growth factor activity eluted from the column with a molec- 
ular weight between 16,000 and 22,000 (6, 22) yielding only 
a ninefold purification with 50% recovery (6). In contrast, the 
high affinity of RDGF for heparin has allowed greater than 
3,500-fold purification with 55% recovery (Table I). Heparin- 
Sepharose chromatography in conjunction with size exclusion 
chromatography or IEF permits a rapid 15,000-fold purifica- 
tion of this potent endothelial mitogen. 
The data presented here on the analysis of RDGF by IEF 
confirms that the molecule is anionic.  In light of this, the 
binding of the anionic growth factor to another anionic mol- 
ecule, heparin, was unexpected. However, a precedent for an 
interaction of this nature occurs in the binding of platelet 
factor  four  (pI  7.6)  to  heparin.  Handin  and  Cohen  (13) 
comment  that  the  heparin-platelet  factor four  interaction 
involves  more  than  "the  neutralization  of charge  by  the 
combination  of a  positively charged protein with  a  highly 
negative aminoglycan" (13). Both the EC surface (3) and its 
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basal lamina (14) contain heparin-like molecules. The binding 
of RDGF  to  these  molecules  would  represent  a  possible 
mechanism for the concentration of  growth factors by cells in 
vivo. The potential significance of the growth factor-heparin 
interaction is emphasized by the recent finding of Thornton 
et al.  (24) who reported that the addition of heparin to the 
culture medium potentiates the stimulatory effect of an EC 
mitogen. 
The finding that the anionic molecule RDGF bound to 
heparin prompted us to investigate whether another anionic 
endothelial mitogen would similarly adhere to heparin. It has 
been demonstrated that the hypothalamus contains an an- 
ionic (pI of 5) factor that stimulates Swiss 3T3 cells as well as 
human umbilical vein EC (18). This factor is reported to exist 
in both a high (75,000) and low (15,000) molecular weight 
form (19). In our studies,  comparison of aHDGF and RDGF 
revealed three major biochemical similarities:  (a) isoelectric 
points of 5.0,  (b) co-elution from heparin-Sepharose at salt 
concentrations of 0.9-1.1  M  NaCI, and (c) co-migration on 
size  exclusion  columns  in  the  molecular weight  range  of 
18,000.  In addition, RDGF and aHDGF exhibit functional 
similarities.  Both growth factors are mitogenic for capillary as 
well as human umbilical vein endothelium (6,  18). Further, 
neither RDGF (10) nor aHDGF (Klagsbrun, M., unpublished 
results) stimulates the proliferation of  vascular smooth muscle 
cells, indicating a target cell specificity.  On the basis of these 
characteristics, we suggest that the two factors isolated from 
two different tissues  are very similar, if not identical mole- 
cules. The pituitary (9) and brain (23) appear also to contain 
an  anionic  growth  factor,  acidic  fibroblast growth  factor, 
which is similar to RDGF and aHDGF. Several characteristics 
of this growth factor, including its isoelectric point (pI of 5), 
its molecular weight (-16,000), and its ability to stimulate 
EC and 3T3 cell proliferation indicate a high degree of simi- 
larity if not identity with RDGF and aHDGF. 
RDGF has been demonstrated to stimulate the proliferation 
of new blood vessels in two in vivo assay systems (5, 10). We 
had postulated that RDGF might function in the retina to 
induce the new capillary formation that characterizes path- 
ologies such as diabetic retinopathy. As of  yet, the biosynthetic 
site of  RDGF is unknown. The existence of  similar or identical 
growth factors in four tissues,  the retina, the hypothalamus, 
the brain, and pituitary, suggests an exciting possibility:  that 
RDGF may be synthesized in the hypothalamus or pituitary 
and then transported to the retina. Several lines of evidence 
support this theory. First, it is well documented that diabetic 
dwarfs do not develop proliferative diabetic retinopathy (20). 
This suggests that normal pituitary-hypothalamus function is 
a prerequisite for the development of retinal vessel prolifera- 
tion. Second, hypophysectomy has been reported to reduce 
the blood vessel growth associated with diabetic retinopathy 
(2), again indicating that an upset of normal hypothalamo- 
hypophyseal interaction removes the stimulus for new blood 
vessel formation. Third, there is an intimate vascular associ- 
ation at the level of the optic chiasm that connects the optic 
nerves, the retina, and the hypothalamohypophyseal system. 
This vascular connection could provide the means for the 
transport of the growth factor/hormone from its site of syn- 
thesis to the retina where it could be stored, further processed, 
destroyed, or transported. Alternatively, since the retina, hy- 
pothalamus, pituitary (9), and brain (Klagsbrun, M., unpub- 
lished results) (15, 23) all appear to contain similar growth 
factors, is that these activities may belong to a class of growth 
factors that are common to all tissues of neural origin. We gratefully acknowledge Yuen Shing for sharing his biochemical 
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